Doodle Teez or Blog

SherringenergyTeez is a creative endeavor to make a visual resource of energy concepts. This blog spot is a place to share information and stories with our personal journeys understanding energy medicine. Sharing creatively so remembering easier and fun. Doodle, Teez or Blog will be sometimes doodles, sometimes drawings, sometimes blogs, cheatsheets of techniques or research study breakdowns. Wearable conversation starters is a passion with a some kind of energy, research or tech connection. A place where I learn by reading, writing and drawing how energy has a relationship in the physical world. This is my way to easily share.

Making energy visible is the goal and sharing is the vehicle ...

Comparing the 2022, 2024, and 2025 Patch Studies

Comparing the 2022, 2024, and 2025 Patch Studies

RESTORE 2025 is the most convincing of the three studies because it adds randomization, blinding, a larger placebo-controlled comparison, and objective mobility outcomes

Comparing the 2022, 2024, and 2025 Patch Studies

The three studies examined whether the FREEDOM haptic patch could help reduce pain. The main difference is how each study was designed and what it measured.

Study designs

  • HARMONI 2022: An observational study of 148 people using the active patch. The reported results did not include a control-group comparison.

Haptic Vibrotactile Trigger Technology: Disrupting the Neuromatrix to Reduce Pain Severity and Interference: Results from the HARMONI Study

  • HARMONI 2024: A larger report with 148 active-patch users and 20 inactive-patch users. However, the paper describes its design inconsistently: the abstract calls it randomized and blinded, while other sections describe an observational study

Using Haptic Technology for Pain Reduction and Functional Improvement

  • RESTORE 2025: A prospective, randomized, double-blind study with 118 participants: 64 received the active patch and 54 received a placebo-like patch.

Reducing Pain and Improving Mobility Using Haptic Patch Technology: Results of the RESTORE Study

Because RESTORE had a more balanced control group and clearer randomized design, it provides a stronger comparison than the HARMONI reports. HARMONI 2024 includes a control group, but its small size and unclear study methods make the results harder to interpret.

What the studies measured

All three studies assessed pain severity and how much pain affected daily life. The HARMONI studies also collected information about medication use, satisfaction, activity, and quality of life.

RESTORE measured these kinds of outcomes too, and added movement tests—including measures of flexibility and range of motion. These tests provided information beyond participants’ reports of how they felt.

Main findings

Pain and daily activities

  • HARMONI 2022: In the active-patch group, average pain severity fell from 4.02 to 2.15 over 14 days—a reported 47% decrease. Pain interference with daily life fell from 2.59 to 1.29, a 50% decrease.
  • HARMONI 2024: The active group showed the same reductions. The 20-person control group showed only small, non-significant changes.
  • RESTORE 2025: The active-patch group had greater improvements in pain severity and pain interference than the placebo group.

Because HARMONI 2022 did not report a control-group comparison, it cannot show whether the improvements were due to the patch or other factors. The comparison groups in HARMONI 2024 and RESTORE offer more context.

Movement and function

RESTORE’s key addition was its measurement of mobility and flexibility. The active-patch group improved more than the placebo group on several movement tests, including measures of lower-back flexibility and joint range of motion.

The HARMONI studies reported improvements in activity and quality of life, but these were mainly based on participants’ answers to surveys rather than objective movement tests.

Medication use, satisfaction, and safety

In HARMONI 2022 and 2024, 82% of active-patch users reported using less or much less oral pain medication after 14 days. Participants in the 2024 active group also reported high satisfaction. RESTORE reported positive satisfaction and no adverse events during the study period; HARMONI reported one non-serious event, local swelling.

These findings are short-term. Participants should not reduce or stop prescribed medication without consulting a healthcare professional.

Overall comparison

  • HARMONI 2022: Early, encouraging results, but the reported analysis focused on people using the active patch and lacked a control comparison.
  • HARMONI 2024: Added an inactive-patch group, but the control group was small and the paper’s description of its study design is inconsistent.
  • RESTORE 2025: The strongest design of the three, with a randomized, double-blind control group and objective movement tests. It reported greater improvements in pain and mobility for the active-patch group than for the placebo group.

More studies are needed to confirm these findings. All three studies had short follow-up, and some outcomes relied on participants’ reports. Larger, independently conducted studies with longer follow-up and clearly described methods would help establish how effective the patch is, who may benefit, and whether improvements last.

One of the biggest problems in these conversations is that people expect research to arrive fully formed. They want the final layer before they are even willing to acknowledge the earlier ones. In this blog (Part 3: Independent Research Usually Comes Later) I explore this.


One-sentence takeaway

RESTORE 2025 is the most convincing of the three studies because it adds randomization, blinding, a larger placebo-controlled comparison, and objective mobility outcomes, whereas the HARMONI papers mainly show self-reported pain improvement and are more vulnerable to bias

Super Patch Blogs

Find Your Super Patches - Quiz

Try Super Patch with SherringSensorySignals

Super Patch Conversation Starters

SHERRINGENERGYTEEZ LINKTREE

©2026 Sherri A Nicholas All Rights Reserved


Categories: : Blog, Brain, Doodle, Research Breakdown, Super Patch

Sherri A. Nicholas

The three wellness approaches I use regularly are Eden Energy Medicine, LifeWave, and Super Patch...

Sherri A. Nicholas

RESTORE 2025 is the most convincing of the three studies because it adds randomization, blinding, a larger placebo-controlled comparison, ...

Sherri A. Nicholas

A simple breakdown of what the RESTORE study tested, what it found, and what still needs a closer look.

Sherri A. Nicholas

The 2024 HARMONI study examined the FREEDOM Super Patch with haptic vibrotactile trigger technology in adults with arthritic, neuropathic, ...

Sherri A. Nicholas

The 2022 HARMONI Study examined the FREEDOM Super Patch with haptic vibrotactile trigger technology in 148 adults with arthritis, nerve, ...

Sherri A. Nicholas

Testimonials are a huge part of the wellness world, and especially of network marketing culture . They help create momentum ...

Load more

Join Me & Let's Have Some Fun